Arthur J. Gallagher & Co: Upside to margins and attractive valuation; Upgrade to Buy
Report Coverage
Full Report Document Access
This page is a research report summary and access guidance page. If you are searching for UBS Arthur J. Gallagher & Co research report PDF or the full report document, use the summary, coverage fields and related links to confirm relevance before requesting access. The full PDF is not publicly displayed on this page.
Report Summary
UBS upgrades Arthur J. Gallagher (AJG) to Buy from Neutral, citing underestimated upside from AssuredPartners synergies ($160m by 2026YE, $300m by early 2028) and AI-driven cost savings (~$730m over 3-5 years). The broker is 70bps above consensus on EBITDAC margins through 2026-28E, and HOLT analysis suggests the market is pricing near 0% terminal organic growth versus UBS’s 5% forecast for 2026-2030E. The PT is lowered to $250 from $283 on a reduced 12x EV/EBITDA target multiple, but the risk/reward is deemed compelling.
Key Takeaways
- Upgrade to Buy from Neutral: AJG offers compelling upside from synergies and AI cost savings at attractive valuation
- AssuredPartners synergies: $160m by 2026YE, increasing to $300m by early 2028E
- AI-driven productivity gains estimated at ~$730m over 3-5 years (~4% of revenue), not yet in base case
- UBS is 70bps above consensus on EBITDAC margins through 2026-28E, targeting ~35% by 2030E
- HOLT framework: market pricing near 0% long-term organic growth vs. UBS/consensus ~5% for 2026-30E
- PT $250 (from $283) at 12x EV/EBITDA NTM (from 13x); current valuation at 11.5x offers attractive entry
Why This Report Matters
AJG’s upgrade highlights how AI adoption and M&A synergies can create hidden margin upside in the insurance brokerage sector. The market’s pricing of near-zero long-term growth appears overly pessimistic given AJG’s track record, making this a contrarian opportunity at 11.5x EV/EBITDA for a company with mid-single-digit organic growth potential.
Topics Covered
Companies Mentioned
Who this summary is for
This summary is for users researching the UBS Arthur J. Gallagher & Co report. It helps users review Arthur J. Gallagher & Co: Upside to margins and attractive valuation; Upgrade to Buy coverage, key takeaways, and related broker or sector research paths across insurance brokerage valuation, AI-driven cost efficiency, M&A synergy realization; Arthur J. Gallagher & Co, AssuredPartners.
Related Search Paths
Use these links to continue through broker, sector and report-type research summaries.